🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Theriva Biologics, Inc. (TOVX)
NYSEAMERICAN: TOVX · Real-Time Price · USD
0.1440
+0.0040 (2.86%)
Nov 18, 2026, 4:00 PM EST - Market closed

Theriva Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-8.73-23.74-25.65-18.35-19.69-14.27
Depreciation & Amortization
0.10.110.140.140.090.09
Loss (Gain) From Sale of Assets
00----
Asset Writedown & Restructuring Costs
--6.92---
Stock-Based Compensation
0.570.650.670.550.480.42
Other Operating Activities
-1.429.370.26-3.640.850.17
Change in Accounts Payable
-0.320.070.12-0.16-0.39-0.36
Change in Other Net Operating Assets
-1.48-3.130.62.47-0.421.07
Operating Cash Flow
-11.28-16.67-16.94-19-19.08-12.89
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.01-0.04-0-0.2-0.12-0.01
Cash Acquisitions
-----3.86-
Investing Cash Flow
-0.01-0.04-0-0.2-4.4-0.01

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-1.51----
Long-Term Debt Repaid
--0.07-0.07-0.08-1.38-
Net Debt Issued (Repaid)
-0.051.44-0.07-0.08-1.38-
Issuance of Common Stock
12.817.475.562.22-74
Repurchase of Common Stock
-----0.29-
Other Financing Activities
-0.45-0.71--1.52-3-
Financing Cash Flow
12.318.195.50.63-1.9374

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.07-0.09-0.13-0.03-0.03-
Net Cash Flow
0.941.4-11.57-18.61-25.4461.1

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-11.29-16.7-16.94-19.2-19.2-12.9
Free Cash Flow Growth
------
Free Cash Flow Per Share
-0.28-1.38-12.56-29.80-31.31-26.47
Levered Free Cash Flow
-7.78-5.98-10.55-14.41-10.42-7.51
Unlevered Free Cash Flow
-7.78-5.98-10.55-14.41-10.42-7.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-1.8-3.060.732.31-0.810.71
SEC Filings: 10-K · 10-Q